Torrent Pharmaceuticals Share Price

  • 3,534.601.80 (0.06%)
  • Volume: 1,93,808
  • Live
  • Last Updated On: 16 Oct, 2025, 03:09 PM IST
High: "4380.00",Open: "3888.35",Low: "3425.00",
Loading...
Torrent Pharmaceuticals Share Price
  • 3,534.601.80 (0.06%)
  • Volume: 1,93,808
Advertisment
Stock Recommendations
  • Potential
    Upside

  • 1 Year
    Target

BUY

Mean Recos by
27 Analysts

0

1

7

14

5

Strong Sell

Sell

Hold

Buy

Strong Buy

Unlock Potential Upside
Stock Reports Plus

/10

Stock Score

View Report
Earnings
Fundamentals
Relative Valuation
Risk
Price Momentum
No Rating (NR)
Negative
Neutral
Positive
Unlock Stock Score

Key Metrics

PE Ratio
(x)
59.68
EPS - TTM
(₹)
59.15
MCap
(₹ Cr.)
1,19,298
Sectoral MCap Rank
4
PB Ratio
(x)
15.75
Div Yield
(%)
0.91
Face Value
(₹)
5.00
Beta

Beta

1 Month-0.02
3 Months0.29
6 Months0.40
1 Year0.50
3 Years0.69

-0.02
VWAP
(₹)
3,532.58
52W H/L
(₹)
3,787.90 / 2,886.45

Torrent Pharma share price insights

View All
  • In the last 20 years, only 2.04 % trading sessions saw intraday gains higher than 5 % .

  • Company has spent 2.19% of its operating revenues towards interest expenses and 19.13% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)

  • 5 day moving crossover appeared yesterday. Average price gain of 2.45% within 7 days of this signal in last 5 years.

  • Torrent Pharmaceuticals Ltd. share price moved up by 0.06% from its previous close of Rs 3,532.80. Torrent Pharmaceuticals Ltd. stock last traded price is 3,534.60

    Share PriceValue
    Today/Current/Last3,534.60
    Previous Day3,532.803,532.25

InsightsTorrent Pharma

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Torrent Pharma Share Price Returns

    1 Day0.06%
    1 Week-0.45%
    1 Month-0.03%
    3 Months2.17%
    1 Year0.55%
    3 Years121.6%
    5 Years157.61%

    ET Stock ScreenersTop Score Companies

    Check whether Torrent Pharma belongs to analysts' top-rated companies list?

    View Stock Screeners

    Torrent Pharma Share Recommendations

    Recent Recos

    BUY

    Current

    Mean Recos by 27 Analysts

    Strong
    Sell
    SellHoldBuyStrong
    Buy
    • Target₹3320
    • OrganizationJM Financial
    • HOLD
    • Target₹2362
    • OrganizationBNP Paribas Securities
    • BUY

    Analyst Trends

    RatingsCurrent1 Week Ago1 Month Ago3 Months Ago
    Strong Buy5554
    Buy14141413
    Hold7776
    Sell1113
    Strong Sell---1
    # Analysts27272727

    Torrent Pharma Financials

    • Insights

      • Employee & Interest Expense

        Company has spent 2.19% of its operating revenues towards interest expenses and 19.13% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)
      Quarterly | AnnualJun 2025Mar 2025Dec 2024Sep 2024Jun 2024
      Total Income3,141.002,941.002,842.002,873.002,883.00
      Total Income Growth (%)6.803.48-1.08-0.353.85
      Total Expenses2,347.002,220.002,094.002,148.002,152.00
      Total Expenses Growth (%)5.726.02-2.51-0.194.21
      EBIT794.00721.00748.00725.00731.00
      EBIT Growth (%)10.12-3.613.17-0.822.81
      Profit after Tax (PAT)548.00498.00503.00453.00457.00
      PAT Growth (%)10.04-0.9911.04-0.881.78
      EBIT Margin (%)25.2824.5226.3225.2325.36
      Net Profit Margin (%)17.4516.9317.7015.7715.85
      Basic EPS (₹)16.1914.7114.8813.3713.51
      Quarterly | AnnualJun 2025Mar 2025Dec 2024Sep 2024Jun 2024
      Total Income2,611.002,448.002,380.002,427.002,459.00
      Total Income Growth (%)6.662.86-1.94-1.3010.82
      Total Expenses1,824.001,779.001,681.001,703.001,728.00
      Total Expenses Growth (%)2.535.83-1.29-1.456.54
      EBIT787.00669.00699.00724.00731.00
      EBIT Growth (%)17.64-4.29-3.45-0.9622.45
      Profit after Tax (PAT)551.00474.00485.00460.00469.00
      PAT Growth (%)16.24-2.275.43-1.9214.39
      EBIT Margin (%)30.1427.3329.3729.8329.73
      Net Profit Margin (%)21.1019.3620.3818.9519.07
      Basic EPS (₹)16.2814.0014.3313.6013.86
      Quarterly | Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue11,539.3610,785.759,665.298,704.608,061.48
      Total Revenue Growth (%)6.9911.5911.047.980.01
      Total Expenses8,842.348,522.027,818.136,993.996,535.22
      Total Expenses Growth (%)3.769.0011.787.02-4.93
      Profit after Tax (PAT)1,911.251,656.381,245.23777.181,251.88
      PAT Growth (%)15.3933.0260.22-37.9222.17
      Operating Profit Margin (%)25.6124.3922.6623.1023.47
      Net Profit Margin (%)16.5915.4412.949.1315.63
      Basic EPS (₹)56.4748.9436.7945.9373.98
      Quarterly | Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue9,713.948,624.267,777.086,946.496,568.91
      Total Revenue Growth (%)12.6410.8911.965.752.55
      Total Expenses7,079.556,707.696,200.065,480.285,202.80
      Total Expenses Growth (%)5.548.1913.135.33-1.62
      Profit after Tax (PAT)1,888.061,357.081,051.39991.451,137.85
      PAT Growth (%)39.1329.076.05-12.8721.24
      Operating Profit Margin (%)29.4126.0124.3625.2526.35
      Net Profit Margin (%)19.4915.9013.6614.7017.63
      Basic EPS (₹)55.7940.1031.0758.5967.24

      All figures in Rs Cr, unless mentioned otherwise

    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets14,989.7415,060.5815,011.8513,099.8414,074.65
      Total Assets Growth (%)-0.470.3214.60-6.930.46
      Total Liabilities7,399.058,204.438,813.787,146.898,237.48
      Total Liabilities Growth (%)-9.82-6.9123.32-13.24-10.33
      Total Equity7,590.696,856.156,198.075,952.955,837.17
      Total Equity Growth (%)10.7110.624.121.9821.02
      Current Ratio (x)1.191.030.981.201.13
      Total Debt to Equity (x)0.400.570.850.670.83
      Contingent Liabilities465.58575.06619.01505.35324.34
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets12,841.7612,376.5912,871.9311,152.5611,761.04
      Total Assets Growth (%)3.76-3.8515.42-5.17-1.04
      Total Liabilities5,249.265,547.836,415.974,807.145,730.94
      Total Liabilities Growth (%)-5.38-13.5333.47-16.12-15.27
      Total Equity7,592.506,828.766,455.966,345.426,030.10
      Total Equity Growth (%)11.185.771.745.2317.75
      Current Ratio (x)1.461.251.151.681.60
      Total Debt to Equity (x)0.340.490.710.530.73
      Contingent Liabilities1,368.981,395.401,448.951,296.421,155.38

      All figures in Rs Cr, unless mentioned otherwise

    • Insights

      • Increase in Cash from Investing

        Company has used Rs 540.05 cr for investing activities which is an YoY increase of 221.65%. (Source: Consolidated Financials)
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities2,585.113,266.082,368.131,802.992,010.69
      Net Cash used in Investing Activities-540.05-167.90-2,415.31-196.63-449.42
      Net Cash flow from Financing Activities-2,297.99-2,779.6477.36-1,781.05-1,656.13
      Net Cash Flow-261.66326.61110.13-174.16-89.26
      Closing Cash & Cash Equivalent573.48835.14508.53398.40572.56
      Closing Cash & Cash Equivalent Growth (%)-31.3364.2327.64-30.42-13.49
      Total Debt/ CFO (x)1.171.212.242.232.40
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities2,574.502,893.102,265.412,140.101,578.23
      Net Cash used in Investing Activities-470.09-296.07-2,384.07-159.70-316.28
      Net Cash flow from Financing Activities-2,104.46-2,577.5780.74-1,977.27-1,586.54
      Net Cash Flow-0.0519.4620.403.13-324.59
      Closing Cash & Cash Equivalent104.81104.8685.4065.0061.87
      Closing Cash & Cash Equivalent Growth (%)-0.0522.7931.385.06-83.99
      Total Debt/ CFO (x)0.991.152.021.562.78

      All figures in Rs Cr, unless mentioned otherwise

    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)25.1724.1520.0913.0521.44
      Return on Capital Employed (%)28.7127.1622.7922.6320.46
      Return on Assets (%)12.7510.998.295.938.89
      Interest Coverage Ratio (x)14.849.698.6610.307.19
      Asset Turnover Ratio (x)0.770.710.680.530.50
      Price to Earnings (x)57.4753.1941.8460.9834.36
      Price to Book (x)14.4212.848.407.957.37
      EV/EBITDA (x)29.8926.6019.6619.3818.62
      EBITDA Margin (%)32.5131.9330.0130.8831.69
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)24.8619.8716.2815.6218.86
      Return on Capital Employed (%)28.8723.6419.8119.5018.53
      Return on Assets (%)14.7010.968.168.889.67
      Interest Coverage Ratio (x)16.909.848.569.756.91
      Asset Turnover Ratio (x)0.770.680.640.590.55
      Price to Earnings (x)58.1464.9449.5047.8537.88
      Price to Book (x)14.4212.898.067.467.13
      EV/EBITDA (x)31.0230.6222.1621.9520.49
      EBITDA Margin (%)37.2534.9333.0934.1835.81

    Financial InsightsTorrent Pharma

    • Income (P&L)
    • Cash Flow
      • Employee & Interest Expense

        Company has spent 2.19% of its operating revenues towards interest expenses and 19.13% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)

      • Increase in Cash from Investing

        Company has used Rs 540.05 cr for investing activities which is an YoY increase of 221.65%. (Source: Consolidated Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Torrent Pharma Share Price Forecast

    • Get multiple analysts’ prediction on Torrent Pharma

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL
    • Get multiple analysts’ prediction on Torrent Pharma

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL
    • Get multiple analysts’ prediction on Torrent Pharma

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    Torrent Pharma Technicals

    • Bullish / Bearish signals for Torrent Pharma basis selected technical indicators and moving average crossovers.

      5 Day EMA Crossover

      Bullish signal on daily chart

      Appeared on: 15 Oct 2025

      5D EMA: 3532.02

      Last 4 Buy Signals:8 Oct 2025
      Date7 days Gain/Loss %
      8 Oct 20250.73%
      29 Sep 20251.42%
      18 Sep 20253.41%
      8 Sep 20251.77%

      Average price gain of 2.45% within 7 days of Bullish signal in last 5 years

      Heikin-Ashi Changeover

      Bullish indication on daily chart

      • Prev. Close Price

        3526.55

      • LTP

        3534.60

      Formed on:

    Torrent Pharma Peer Comparison

      • 1D
      • 1W
      • 1M
      • 3M
      • 6M
      • 1Y
      • 5Y
      Loading...
    • Ratio Performance

      NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
      Torrent Pharma59.7115.7525.1728.7112.759.7525.6116.5956.471.190.401.17
      Divis Labs76.0311.7114.6318.8512.932.2731.1723.4082.536.940.000.00
      Cipla23.514.0516.9021.5714.108.7324.9819.2065.294.250.000.02
      Dr. Reddys18.223.0516.8521.8111.4415.1124.3217.4767.891.920.120.90
      Mankind Pharma53.546.9613.8913.277.1716.7224.0316.3749.281.230.593.51
      Add More
      Annual Ratios (%)

      Choose from Peers

      • Cadila Healthcare
      • Lupin
      • Alkem Labs
      • Aurobindo Pharma
      • Glenmark Pharma

      Choose from Stocks

      Peers InsightsTorrent Pharma

        Do you find these insights useful?

        • hate it

        • meh

        • love it

        Torrent Pharma Shareholding Pattern

        • Loading...
          Showing Torrent Pharma Shareholding as on Sep 2025
          CategorySep 2025Jun 2025Mar 2025Dec 2024
          Promoters68.3168.3168.3168.31
          Pledge0.000.000.000.00
          FII15.9216.0916.3116.16
          DII9.178.548.258.25
          Mutual Funds5.124.955.034.88
          Others6.597.067.127.28
        • Showing Shareholding as on Sep 2025
          CategoryNo. of SharesPercentage% Change QoQ
          Promoters23,11,85,40068.31 %0.00
          Pledge00.00 %0.00
          FII5,38,75,20015.92 %-0.16
          DII3,10,75,7039.17 %0.62
          MF1,73,42,1355.12 %0.16
          Others2,23,09,1376.59 %-0.46

        Torrent Pharma MF Ownership

        MF Ownership as on 30 September 2025

        Torrent Pharma F&O Quote

          • Expiry

          Price

          3,541.60-3.60 (-0.10%)

          Open Interest

          23,27,750-7,750 (-0.33%)

          OpenHighLowPrev CloseContracts TradedTurnover (₹ Lakhs)
          3,548.503,561.003,526.503,545.202203,908.37

          Open Interest as of 16 Oct 2025

          • Type
          • Expiry
          • Strike Price

          Price

          45.30-0.75 (-1.63%)

          Open Interest

          1,26,50022,750 (21.93%)

          OpenHighLowPrev CloseContracts TradedTurnover (₹ Lakhs)
          46.0552.6041.0046.052564,604.77

          Open Interest as of 16 Oct 2025

        Torrent Pharma Corporate Actions

        • Meeting DateAnnounced onPurposeDetails
          Jul 28, 2025Jul 21, 2025Board MeetingQuarterly Results & Others
          May 20, 2025May 14, 2025Board MeetingAudited Results, Final Dividend & Others
          Jan 24, 2025Jan 13, 2025Board MeetingQuarterly Results & Others
          Oct 25, 2024Oct 10, 2024Board MeetingQuarterly Results
          Jul 23, 2024Jul 05, 2024Board MeetingQuarterly Results
        • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
          Final120%6.0Jun 20, 2025May 20, 2025
          Interim520%26.0Jan 31, 2025Jan 14, 2025
          Final120%6.0Jun 21, 2024May 24, 2024
          Interim440%22.0Feb 12, 2024Jan 12, 2024
          Final160%8.0Jun 23, 2023May 30, 2023
        • All TypesEx-DateRecord DateAnnounced onDetails
          BonusJul 08, 2022Jul 11, 2022May 25, 2022Bonus Ratio: 1 share(s) for every 1 shares held
          BonusJul 23, 2013Jul 24, 2013May 30, 2013Bonus Ratio: 1 share(s) for every 1 shares held
          SplitsFeb 20, 2006Feb 27, 2006Dec 15, 2005Split: Old FV10.0| New FV:5.0
          BonusFeb 20, 2006Feb 27, 2006Dec 15, 2005Bonus Ratio: 1 share(s) for every 1 shares held

        About Torrent Pharma

        Torrent Pharmaceuticals Ltd., incorporated in the year 1972, is a Large Cap company (having a market cap of Rs 1,19,566.01 Crore) operating in Pharmaceuticals sector. Torrent Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue and Export Incentives for the year ending 31-Mar-2025. Show More

        • Executives

        • Auditors

        • SM

          Sudhir Mehta

          Chairman Emeritus
          SM

          Samir Mehta

          Executive Chairman
          AS

          Aman Samir Mehta

          Whole Time Director
          JM

          Jinal Mehta

          Non Executive Director
          Show More
        • BSR & Co. LLP

        FAQs about Torrent Pharma share

        • 1. What's the Torrent Pharma share price today?
          Torrent Pharma share price is Rs 3,532.40 as on 16 Oct, 2025, 02:46 PM IST. Torrent Pharma share price is down by 0.02% based on previous share price of Rs. 3522.0.
        • 2. What are the returns for Torrent Pharma share?
          Return Performance of Torrent Pharma Shares:
          • 1 Week: Torrent Pharma share price moved down by 0.51%
          • 6 Month: Torrent Pharma share price moved up by 9.61%
        • 3. What's the market capitalization of Torrent Pharma?
          Market Capitalization of Torrent Pharma stock is Rs 1,19,207 Cr.
        • 4. What is the PE & PB ratio of Torrent Pharma?
          The PE ratio of Torrent Pharma stands at 59.72, while the PB ratio is 15.73.
        • 5. What is Torrent Pharma's 52 week high / low?
          In last 52 weeks Torrent Pharma share had a high price of Rs 3,787.90 and low price of Rs 2,886.45

        Trending in Markets

        Top Gainers As on 03:01 PM | 16 Oct 2025

        BLS Int. Services321.70
        43.15 (15.50%)
        Craftsman Automation6,803.50
        379.50 (5.91%)
        Oberoi Realty1,685.50
        84.10 (5.26%)
        Apar Industries8,793.50
        438.00 (5.25%)
        ITI Ltd341.50
        16.40 (5.05%)

        Top Losers As on 03:07 PM | 16 Oct 2025

        KEI Industries4,171.40
        -249.21 (-5.64%)
        Netweb Technologies3,761.80
        -170.60 (-4.34%)
        Anant Raj634.95
        -27.60 (-4.17%)
        Max Financial1,551.80
        -57.30 (-3.57%)
        Tata Investment908.00
        -33.00 (-3.51%)

        DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

        DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

        By using this site, you agree to the Terms of Service and Privacy Policy.

        The Economic Times